Cargando…
Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice
Sampling of blood at home to determine the concentration of drugs or other compounds can be effective in limiting hospital-based sampling. This could lower hospital visits and patient burden, improve the quality of life, and reduce health care costs. Dried blood spot (DBS) microsampling is often use...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Therapeutic Drug Monitoring
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467683/ https://www.ncbi.nlm.nih.gov/pubmed/35607881 http://dx.doi.org/10.1097/FTD.0000000000000994 |
_version_ | 1784788241819369472 |
---|---|
author | Francke, Marith I. Peeters, Laura E. J. Hesselink, Dennis A. Kloosterboer, Sanne M. Koch, Birgit C. P. Veenhof, Herman de Winter, Brenda C. M. |
author_facet | Francke, Marith I. Peeters, Laura E. J. Hesselink, Dennis A. Kloosterboer, Sanne M. Koch, Birgit C. P. Veenhof, Herman de Winter, Brenda C. M. |
author_sort | Francke, Marith I. |
collection | PubMed |
description | Sampling of blood at home to determine the concentration of drugs or other compounds can be effective in limiting hospital-based sampling. This could lower hospital visits and patient burden, improve the quality of life, and reduce health care costs. Dried blood spot (DBS) microsampling is often used for this purpose, wherein capillary blood, obtained by pricking the heel or finger, is used to measure different analytes. Although DBS has several advantages over venous blood sampling, it is not routinely implemented in clinical practice. To facilitate the bench to bedside transition, it is important to be aware of certain challenges that need to be considered and addressed. RESULTS: Here, important considerations regarding the implementation of DBS in clinical practice, the choice of patients, blood sampling, transport, and laboratory analysis are discussed. In addition, we share our experience and provide suggestions on how to deal with these problems in a clinical setting. |
format | Online Article Text |
id | pubmed-9467683 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Therapeutic Drug Monitoring |
record_format | MEDLINE/PubMed |
spelling | pubmed-94676832022-09-13 Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice Francke, Marith I. Peeters, Laura E. J. Hesselink, Dennis A. Kloosterboer, Sanne M. Koch, Birgit C. P. Veenhof, Herman de Winter, Brenda C. M. Ther Drug Monit Short Communication Sampling of blood at home to determine the concentration of drugs or other compounds can be effective in limiting hospital-based sampling. This could lower hospital visits and patient burden, improve the quality of life, and reduce health care costs. Dried blood spot (DBS) microsampling is often used for this purpose, wherein capillary blood, obtained by pricking the heel or finger, is used to measure different analytes. Although DBS has several advantages over venous blood sampling, it is not routinely implemented in clinical practice. To facilitate the bench to bedside transition, it is important to be aware of certain challenges that need to be considered and addressed. RESULTS: Here, important considerations regarding the implementation of DBS in clinical practice, the choice of patients, blood sampling, transport, and laboratory analysis are discussed. In addition, we share our experience and provide suggestions on how to deal with these problems in a clinical setting. Therapeutic Drug Monitoring 2022-10 2022-05-23 /pmc/articles/PMC9467683/ /pubmed/35607881 http://dx.doi.org/10.1097/FTD.0000000000000994 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Communication Francke, Marith I. Peeters, Laura E. J. Hesselink, Dennis A. Kloosterboer, Sanne M. Koch, Birgit C. P. Veenhof, Herman de Winter, Brenda C. M. Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice |
title | Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice |
title_full | Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice |
title_fullStr | Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice |
title_full_unstemmed | Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice |
title_short | Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice |
title_sort | best practices to implement dried blood spot sampling for therapeutic drug monitoring in clinical practice |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467683/ https://www.ncbi.nlm.nih.gov/pubmed/35607881 http://dx.doi.org/10.1097/FTD.0000000000000994 |
work_keys_str_mv | AT franckemarithi bestpracticestoimplementdriedbloodspotsamplingfortherapeuticdrugmonitoringinclinicalpractice AT peeterslauraej bestpracticestoimplementdriedbloodspotsamplingfortherapeuticdrugmonitoringinclinicalpractice AT hesselinkdennisa bestpracticestoimplementdriedbloodspotsamplingfortherapeuticdrugmonitoringinclinicalpractice AT kloosterboersannem bestpracticestoimplementdriedbloodspotsamplingfortherapeuticdrugmonitoringinclinicalpractice AT kochbirgitcp bestpracticestoimplementdriedbloodspotsamplingfortherapeuticdrugmonitoringinclinicalpractice AT veenhofherman bestpracticestoimplementdriedbloodspotsamplingfortherapeuticdrugmonitoringinclinicalpractice AT dewinterbrendacm bestpracticestoimplementdriedbloodspotsamplingfortherapeuticdrugmonitoringinclinicalpractice |